EPIRUS BIOPHARMACEUTICALS INC Inactive Instrument
Company Epirus Biopharmaceuticals Inc Other OTC
Equities
US29428P1075
Biotechnology & Medical Research
Business Summary
Sales per Business
| USD in Million | 2014 | Weight | 2015 | Weight | Delta |
|---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +17,425.00% |
Sales per region
| USD in Million | 2014 | Weight | 2015 | Weight | Delta |
|---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +17,425.00% |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 26,184,349 | 26,184,349 ( 100.00 %) | 0 | 100.00 % |
Company contact information
EPIRUS Biopharmaceuticals, Inc.
699 Boylston Street 8th floor
02116, Boston
+617-600-3497
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +4.09% | 43.43B | |
| +47.81% | 41.69B | |
| +9.45% | 41.31B | |
| -10.92% | 27.14B | |
| +9.32% | 25.28B | |
| -24.87% | 18.47B | |
| +29.70% | 12.59B | |
| +1.28% | 12.33B | |
| +7.78% | 11.03B |
